bupropion has been researched along with Seizures in 103 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sustained-release bupropion (bupropion SR) was first launched in the US in 1997 as an aid to smoking cessation and has since been launched in many other countries." | 8.81 | Tolerability and safety of sustained-release bupropion in the management of smoking cessation. ( Aubin, HJ, 2002) |
| "Bupropion is an effective treatment for major depressive disorder and smoking cessation." | 8.02 | Acute dystonia following epileptic seizure after bupropion intoxication. ( Çim, EFA; Kamış, GZ; Kurhan, F, 2021) |
| " She was determined to be postictal after a witnessed new-onset seizure 4 days after starting bupropion for smoking cessation." | 7.96 | New-Onset Seizure in Patient Medicated With Bupropion for Smoking Cessation: A Case Report. ( Lovett, S; Rech, MA; Saffaei, D, 2020) |
| "Delayed seizures have been reported with overdoses of bupropion extended-release (XL)." | 7.75 | Incidence and onset of delayed seizures after overdoses of extended-release bupropion. ( Ekleberry, SE; Kern, P; Klein-Schwartz, W; Kunkel, S; Spiller, H; Starr, P, 2009) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 7.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| "Bupropion (amfebutamone) enters maternal milk, with a potential risk of seizures in breast-feeding infants." | 7.73 | Bupropion: seizures in an infant exposed through breast-feeding. ( , 2005) |
| "Bupropion is a relatively new and popular medication with seizures as its major side effect." | 7.71 | Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. ( Avasarala, J; Pesola, GR, 2002) |
| "5 mg/kg) significantly decreased latencies to generalized motor seizures induced 12 h later by the noncompetitive GABAA receptor antagonist picrotoxin (10 mg/kg)." | 7.68 | Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures. ( Borowski, TB; Kirkby, RD; Kokkinidis, L, 1993) |
| "The relationship between seizure occurrence and use of bupropion was examined on the basis of manufacturer's reports." | 6.38 | Seizures and bupropion: a review. ( Davidson, J, 1989) |
| "The incidence of convulsions in patients receiving tricyclic antidepressants or bupropion was reviewed." | 6.36 | Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. ( Peck, AW; Stern, WC; Watkinson, C, 1983) |
| "Bupropion is an atypical antidepressant often used in the treatment of depression, tobacco cessation, seasonal affective disorder, and off label for ADHD." | 5.72 | Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine. ( Robinson, S, 2022) |
| "She had a seizure and required sedation and intubation." | 5.62 | Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine. ( Beau, J; Bolton, TA; Carpenter, JE; Kazzi, Z; Kiernan, EA; Murray, BP; Sayers, J; Wolf, MJ; Yeh, M, 2021) |
| "Bupropion pretreatment attenuated KA-induced neuronal cell death and microglia activation in the CA3 region of the hippocampus." | 5.39 | Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus. ( Lin, KC; Wang, CC; Wang, SJ, 2013) |
| "However, the seizure threshold may be influenced by psychotropic drugs." | 5.37 | Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. ( Dersch, R; Voderholzer, U; Zwernemann, S, 2011) |
| "Bupropion is a newer generation antidepressant that is commonly used for treatment of depression and for smoking cessation." | 5.36 | Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. ( Kim, D; Steinhart, B, 2010) |
| "Elderly (> or = 60 years) outpatients with major depressive disorder (DSM-IV criteria) were evaluated in this 6-week multicenter, randomized, double-blind study comparing bupropion SR, 100-300 mg/day, and paroxetine, 10-40 mg/day." | 5.09 | Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. ( Ascher, JA; Batey, SR; Donahue, RM; Houser, TL; Settle, EC; Weihs, KL, 2000) |
| "This prospective 105-site study was conducted to determine the rate of seizures and other serious adverse experiences associated with the therapeutic use of the sustained-release formulation of bupropion (bupropion SR)." | 5.08 | A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. ( Ascher, JA; Batey, SR; Billow, AA; Dunner, DL; Johnston, JA; Zisook, S, 1998) |
| "This trial was conducted to determine the incidence of seizures associated with the use of bupropion." | 5.07 | A 102-center prospective study of seizure in association with bupropion. ( Ascher, JA; Davidson, J; Feighner, JP; Johnston, JA; Khayrallah, MA; Lineberry, CG; Stark, P, 1991) |
| "Seizures of both immediate and delayed onset after ingestion of bupropion SR and bupropion XL formulations are well documented, but are less well characterized after insufflation." | 4.90 | An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System. ( Albertson, TE; Ford, JB; Lewis, JC; Owen, KP; Sutter, ME, 2014) |
| "Bupropion hydrochloride is a monocyclic antidepressant which is used in a slow-release formulation as a smoking cessation aid." | 4.81 | Zyban-- is there a cause for concern? ( Tracey, JA, 2002) |
| "Sustained-release bupropion (bupropion SR) was first launched in the US in 1997 as an aid to smoking cessation and has since been launched in many other countries." | 4.81 | Tolerability and safety of sustained-release bupropion in the management of smoking cessation. ( Aubin, HJ, 2002) |
| "Increasing age, seizures, QRS widening, and QTc prolongation were associated with adverse cardiovascular events in bupropion exposures." | 4.31 | Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion exposures. ( Burns, MM; Feng, C; Monuteaux, M; Simpson, M; Troger, A; Whitledge, JD, 2023) |
| "Bupropion is an effective treatment for major depressive disorder and smoking cessation." | 4.02 | Acute dystonia following epileptic seizure after bupropion intoxication. ( Çim, EFA; Kamış, GZ; Kurhan, F, 2021) |
| " She was determined to be postictal after a witnessed new-onset seizure 4 days after starting bupropion for smoking cessation." | 3.96 | New-Onset Seizure in Patient Medicated With Bupropion for Smoking Cessation: A Case Report. ( Lovett, S; Rech, MA; Saffaei, D, 2020) |
| "Of the 266 recorded single bupropion overdoses, the most common symptoms were seizures (47." | 3.96 | Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity. ( Alsukaiti, WS; Calello, DP; Carpenter, J; Dunkley, C; Kazzi, Z; Kiernan, EA; Moran, TP; Murray, B; Rianprakaisang, T, 2020) |
| "Bupropion is associated with a dose-dependent increased risk of seizures." | 3.85 | Concurrent Electroconvulsive Therapy and Bupropion Treatment. ( Geske, JR; Leung, JG; Murphy, LL; Palmer, BA; Takala, CR, 2017) |
| "Bupropion overdose commonly causes generalized seizures and central nervous system depression." | 3.79 | Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. ( Al-Abri, SA; Benowitz, NL; Hayashi, S; Olson, KR; Orengo, JP; Thoren, KL, 2013) |
| "The incidence of seizures after unintentional bupropion ingestion in children aged < 6 years has been reported as 0." | 3.76 | Unintentional ingestion of bupropion in children. ( Baker, SD; Beuhler, M; Bosse, GM; Gray, T; Spiller, HA, 2010) |
| "Unintentional bupropion pediatric exposures uncommonly report severe clinical effects such as seizures." | 3.76 | The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. ( Beuhler, MC; Sasser, HC; Spiller, HA, 2010) |
| "The risk of dose-dependent seizures is a safety issue with bupropion hydrochloride." | 3.76 | Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings. ( Baker, B; D'Empaire, I; Liow, K; Macaluso, M; Preskorn, SH; Zackula, R, 2010) |
| "Delayed seizures have been reported with overdoses of bupropion extended-release (XL)." | 3.75 | Incidence and onset of delayed seizures after overdoses of extended-release bupropion. ( Ekleberry, SE; Kern, P; Klein-Schwartz, W; Kunkel, S; Spiller, H; Starr, P, 2009) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 3.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| "Bupropion, an atypical antidepressant commonly used for depression and smoking cessation, is well known to cause seizures in both therapeutic use and overdose, but cardiac effects have been reported as minimal, usually sinus tachycardia." | 3.74 | Cardiotoxicity associated with accidental bupropion ingestion in a child. ( Gabrysch, J; Givens, ML, 2007) |
| "Bupropion (amfebutamone) enters maternal milk, with a potential risk of seizures in breast-feeding infants." | 3.73 | Bupropion: seizures in an infant exposed through breast-feeding. ( , 2005) |
| "Bupropion use is probably associated with an increased risk of seizures, but no evidence was found to suggest that the drug is associated with an increased risk of sudden death." | 3.73 | Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. ( Britton, J; Farrington, P; Godfrey, C; Hubbard, R; Lewis, S; Smeeth, L; Smith, C; West, J, 2005) |
| "Bupropion is a relatively new and popular medication with seizures as its major side effect." | 3.71 | Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. ( Avasarala, J; Pesola, GR, 2002) |
| "We report a case of a 26-year-old man who ingested 23 g bupropion, developed seizures and hypoxia, and presented in cardiac arrest." | 3.69 | Fatal bupropion overdose. ( Gualtieri, J; Harris, CR; Stark, G, 1997) |
| "5 mg/kg) significantly decreased latencies to generalized motor seizures induced 12 h later by the noncompetitive GABAA receptor antagonist picrotoxin (10 mg/kg)." | 3.68 | Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures. ( Borowski, TB; Kirkby, RD; Kokkinidis, L, 1993) |
| "Bupropion is an aminoketone antidepressant." | 2.72 | Factors associated with seizure development after bupropion overdose: a review of the toxicology investigators consortium. ( Hendrickson, RG; Lin, AL; Murray, BP; Prather, CT; Rianprakaisang, TN, 2021) |
| "The incidence of a seizure was less than 1 per 1,000 at usual outpatient doses and less than 1 per 100 at usual inpatient doses." | 2.65 | Overview of clinically significant adverse reactions to bupropion. ( Cato, AE; Fleck, RJ; Harto-Truax, N; Manberg, PJ; Miller, LL; Sato, T; Stern, WC; Van Wyck Fleet, J, 1983) |
| "Bupropion is an effective therapy for smoking cessation and is recommended as first-line treatment in both US and UK guidelines." | 2.43 | Bupropion: risks and benefits. ( Ross, S; Williams, D, 2005) |
| "Bupropion is a relatively new monocyclic antidepressant whose mechanism of action remains unknown." | 2.41 | Bupropion overdose in an adolescent. ( Ayers, S; Tobias, JD, 2001) |
| "Study data demonstrate that seizure incidence, which is a concern with high-dose IR, is substantially lower with the new SR formulation." | 2.40 | Bupropion sustained release: side effect profile. ( Settle, EC, 1998) |
| "The relationship between seizure occurrence and use of bupropion was examined on the basis of manufacturer's reports." | 2.38 | Seizures and bupropion: a review. ( Davidson, J, 1989) |
| "Nomifensine was withdrawn from markets worldwide because of reports of serious hypersensitivity reactions, especially hemolytic anemia, and marketing of bupropion in the United States was delayed after seizures occurred in bulimic patients in clinical trials." | 2.37 | Adverse reactions to five new antidepressants. ( Hayes, PE; Kristoff, CA, 1986) |
| "The incidence of convulsions in patients receiving tricyclic antidepressants or bupropion was reviewed." | 2.36 | Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. ( Peck, AW; Stern, WC; Watkinson, C, 1983) |
| "Bupropion is widely used for the treatment of major depressive disorder and for smoking cessation assistance." | 1.91 | The role of decision tree and machine learning models for outcome prediction of bupropion exposure: A nationwide analysis of more than 14 000 patients in the United States. ( Abdollahi, J; Goss, F; Mehrpour, O; Saeedi, F; Shirazi, FM; Vohra, V, 2023) |
| "Bupropion is an atypical antidepressant often used in the treatment of depression, tobacco cessation, seasonal affective disorder, and off label for ADHD." | 1.72 | Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine. ( Robinson, S, 2022) |
| "Bupropion is an antidepressant with unique mechanisms of action leading to a narrow therapeutic window." | 1.72 | Disposition, outcomes, and lengths of stay due to bupropion overdose at a tertiary care center with a medical toxicology service. ( McCabe, DJ; Radke, JB; Wilson, BZ, 2022) |
| "Bupropion is an antidepressant medication with expanding indications including smoking cessation, weight loss, attention-deficit/hyperactivity disorder, seasonal affective disorder, and amphetamine dependence." | 1.72 | The Timing of Clinical Effects of Bupropion Misuse Via Insufflation Reported to a Regional Poison Center. ( McCabe, DJ; McGillis, E; Willenbring, BA, 2022) |
| "She had a seizure and required sedation and intubation." | 1.62 | Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine. ( Beau, J; Bolton, TA; Carpenter, JE; Kazzi, Z; Kiernan, EA; Murray, BP; Sayers, J; Wolf, MJ; Yeh, M, 2021) |
| "Safer agents that do not lower the seizure threshold should be utilized whenever possible." | 1.62 | Bupropion With Clozapine: Case Reports of Seizure After Coadministration. ( Botner, B; Hund, M; Schmitz, A, 2021) |
| "Bupropion is a unique class of antidepressant." | 1.56 | Pediatric Bupropion Ingestions in Adolescents vs. Younger Children-a Tale of Two Populations. ( Gosen, J; Levine, M; Offerman, S; Thomas, SH, 2020) |
| "Bupropion is a commonly used antidepressant, and overdose can lead to both neurologic and cardiovascular toxicity, including agitation, seizure, tachycardia, QT and QRS prolongation, and rhythm disturbances." | 1.51 | Pediatric Toxidrome Simulation Curriculum: Bupropion Overdose. ( Burns, R; Hartford, E; Keilman, A; Reid, J; Stone, K; Thomas, A; Uspal, N, 2019) |
| "It is unknown whether the risk of seizure during therapeutic use differs by drug." | 1.48 | Second-generation anti-depressants and risk of new-onset seizures in the elderly. ( Finkelstein, Y; Gomes, T; Juurlink, DN; Li, P; Macdonald, EM; Mamdani, MM, 2018) |
| "Bupropion is an atypical antidepressant that is structurally similar to amphetamines." | 1.43 | Atypical Findings in Massive Bupropion Overdose: A Case Report and Discussion of Psychopharmacologic Issues. ( Jimenez, XF; Kolawole, T; Zhu, Y, 2016) |
| "Bupropion pretreatment attenuated KA-induced neuronal cell death and microglia activation in the CA3 region of the hippocampus." | 1.39 | Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus. ( Lin, KC; Wang, CC; Wang, SJ, 2013) |
| " Chronic administration of bupropion significantly potentiates the protective activity of lamotrigine, topiramate, and felbamate against maximal electroshock-induced seizures." | 1.37 | Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice. ( Bańka, K; Barczyński, B; Buszewicz, G; Mądro, R; Mróz, T; Tutaj, K; Tutka, P; Wielosz, M; Łuszczki, JJ, 2011) |
| "However, the seizure threshold may be influenced by psychotropic drugs." | 1.37 | Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. ( Dersch, R; Voderholzer, U; Zwernemann, S, 2011) |
| "Bupropion and tramadol were discontinued, and seizures did not recur." | 1.36 | Which xenobiotic(s) could be responsible for the radiologic findings below? Answer: any proconvulsant xenobiotic, in this case tramadol, bupropion, and nortriptyline. ( Roberts, DJ; Stellpflug, SJ, 2010) |
| "Bupropion is a newer generation antidepressant that is commonly used for treatment of depression and for smoking cessation." | 1.36 | Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. ( Kim, D; Steinhart, B, 2010) |
| "To estimate the rate of new-onset seizure in ADHD patients in relation to ADHD pharmacotherapy." | 1.35 | The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. ( Holdridge, KC; Hornbuckle, K; Johannes, CB; McAfee, AT; Walker, AM, 2008) |
| "On arrival at hospital seizures arose." | 1.34 | Bupropion interference with immunoassays for amphetamines and LSD. ( Skripuletz, T; Vidal, C, 2007) |
| "Diazepam treatment alone and before cocaine overdose did not interfere with catalase activity." | 1.33 | Cocaine alters catalase activity in prefrontal cortex and striatum of mice. ( Aguiar, LM; de Sousa, FC; de Vasconcelos, SM; dos Santos, RS; Lima, VT; Macêdo, DS; Viana, GS, 2005) |
| "Seizures were dose-dependent, with those having seizures ingesting a significantly higher median dose (P = 0." | 1.32 | Bupropion poisoning: a case series. ( Balit, CR; Isbister, GK; Lynch, CN, 2003) |
| "We suggest that sleep deprivation may add to the risk of bupropion-associated seizures." | 1.32 | Seizure associated with sleep deprivation and sustained-release bupropion. ( Duckrow, RB; Oncken, CA, 2003) |
| "Bupropion is an antidepressant that has recently seen increased usage in smoking cessation." | 1.32 | Intentional bupropion overdoses. ( Keyes, DC; Shepherd, G; Velez, LI, 2004) |
| "We describe a prolonged seizure occurring during the first treatment of a course of ECT in an adult patient receiving long-term bupropion therapy, lithium, and venlafaxine." | 1.31 | The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity. ( Conway, CR; Nelson, LA, 2001) |
| "Bupropion is a monocyclic antidepressant structurally related to amphetamine." | 1.31 | Bupropion (Zyban) toxicity. ( Ali, I; Casey, PB; Cassidy, N; Tracey, JA, 2002) |
| "Bupropion is an antidepressant and smoking cessation aid." | 1.31 | Bupropion exposures: clinical manifestations and medical outcome. ( Belson, MG; Kelley, TR, 2002) |
| "Seizure is the primary adverse reaction associated with bupropion overdoses." | 1.30 | ECG conduction delays associated with massive bupropion overdose. ( Paris, PA; Saucier, JR, 1998) |
| "Bupropion is a novel new antidepressant without the undesirable anticholinergic, cardiotoxic, sedative, or sexual side effects of other available antidepressants." | 1.27 | A case of bupropion-induced seizure. ( Fishman, SM; Sheehan, DV; Welch, JB, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (7.77) | 18.7374 |
| 1990's | 16 (15.53) | 18.2507 |
| 2000's | 38 (36.89) | 29.6817 |
| 2010's | 24 (23.30) | 24.3611 |
| 2020's | 17 (16.50) | 2.80 |
| Authors | Studies |
|---|---|
| McCabe, DJ | 2 |
| McGillis, E | 1 |
| Willenbring, BA | 1 |
| Radke, JB | 1 |
| Wilson, BZ | 1 |
| Robinson, S | 1 |
| Rodríguez, PM | 1 |
| Fernández Revuelta, A | 1 |
| Romeral Jiménez, M | 1 |
| Parejo Carbonell, B | 1 |
| Horga Hernández, A | 1 |
| Ramos García, I | 1 |
| Polidura Arruga, C | 1 |
| Garcia-Morales, I | 1 |
| Mehrpour, O | 1 |
| Saeedi, F | 1 |
| Vohra, V | 1 |
| Abdollahi, J | 1 |
| Shirazi, FM | 1 |
| Goss, F | 1 |
| Simpson, M | 1 |
| Troger, A | 1 |
| Feng, C | 1 |
| Whitledge, JD | 1 |
| Monuteaux, M | 1 |
| Burns, MM | 1 |
| Offerman, S | 2 |
| Levine, M | 2 |
| Gosen, J | 2 |
| Thomas, SH | 2 |
| Murray, B | 1 |
| Carpenter, J | 1 |
| Dunkley, C | 1 |
| Moran, TP | 1 |
| Kiernan, EA | 2 |
| Rianprakaisang, T | 1 |
| Alsukaiti, WS | 1 |
| Calello, DP | 1 |
| Kazzi, Z | 2 |
| Hartford, E | 1 |
| Thomas, A | 1 |
| Keilman, A | 1 |
| Uspal, N | 1 |
| Stone, K | 1 |
| Reid, J | 1 |
| Burns, R | 1 |
| Saffaei, D | 1 |
| Lovett, S | 1 |
| Rech, MA | 1 |
| Schmitz, A | 1 |
| Botner, B | 1 |
| Hund, M | 1 |
| Padilla-Jones, A | 1 |
| Ruha, AM | 1 |
| Parikh, NS | 1 |
| Salehi Omran, S | 1 |
| Kamel, H | 1 |
| Elkind, MSV | 1 |
| Willey, JZ | 1 |
| Murray, BP | 2 |
| Carpenter, JE | 1 |
| Sayers, J | 1 |
| Yeh, M | 1 |
| Beau, J | 1 |
| Wolf, MJ | 1 |
| Bolton, TA | 1 |
| Kurhan, F | 1 |
| Kamış, GZ | 1 |
| Çim, EFA | 1 |
| Rianprakaisang, TN | 1 |
| Prather, CT | 1 |
| Lin, AL | 1 |
| Hendrickson, RG | 1 |
| Sathe, AR | 1 |
| Thiemann, A | 1 |
| Toulouie, S | 1 |
| Durant, E | 1 |
| Herr, J | 1 |
| Hatch, L | 1 |
| Sephien, A | 1 |
| Hanna, K | 1 |
| Takala, CR | 1 |
| Leung, JG | 1 |
| Murphy, LL | 1 |
| Geske, JR | 1 |
| Palmer, BA | 1 |
| Mishra, DK | 1 |
| Sardesai, U | 1 |
| Rastogi, P | 1 |
| Finkelstein, Y | 2 |
| Macdonald, EM | 1 |
| Li, P | 1 |
| Mamdani, MM | 1 |
| Gomes, T | 1 |
| Juurlink, DN | 1 |
| Yang, YC | 1 |
| Yeh, TC | 1 |
| Liang, CS | 1 |
| Lin, KC | 1 |
| Wang, CC | 1 |
| Wang, SJ | 1 |
| Al-Abri, SA | 1 |
| Orengo, JP | 1 |
| Hayashi, S | 1 |
| Thoren, KL | 1 |
| Benowitz, NL | 1 |
| Olson, KR | 1 |
| Stall, N | 1 |
| Godwin, J | 1 |
| Juurlink, D | 1 |
| Lewis, JC | 1 |
| Sutter, ME | 1 |
| Albertson, TE | 1 |
| Owen, KP | 1 |
| Ford, JB | 1 |
| Sharma, A | 1 |
| Thakar, S | 1 |
| Lavie, CJ | 1 |
| Garg, J | 1 |
| Krishnamoorthy, P | 1 |
| Sochor, O | 1 |
| Arbab-Zadeh, A | 1 |
| Lichstein, E | 1 |
| Castelnovo, A | 1 |
| Zambrelli, E | 1 |
| Canevini, MP | 1 |
| Cavallotti, S | 1 |
| Scarone, S | 1 |
| D'Agostino, A | 1 |
| Weerdenburg, K | 1 |
| Zhu, Y | 1 |
| Kolawole, T | 1 |
| Jimenez, XF | 1 |
| Spiller, HA | 3 |
| Schaeffer, SE | 1 |
| Bosse, GM | 1 |
| Beuhler, M | 1 |
| Gray, T | 1 |
| Baker, SD | 1 |
| McAfee, AT | 1 |
| Holdridge, KC | 1 |
| Johannes, CB | 1 |
| Hornbuckle, K | 1 |
| Walker, AM | 1 |
| Beyens, MN | 1 |
| Guy, C | 1 |
| Mounier, G | 1 |
| Laporte, S | 1 |
| Ollagnier, M | 1 |
| Starr, P | 1 |
| Klein-Schwartz, W | 1 |
| Spiller, H | 1 |
| Kern, P | 1 |
| Ekleberry, SE | 1 |
| Kunkel, S | 1 |
| Beuhler, MC | 1 |
| Sasser, HC | 1 |
| Kim, D | 1 |
| Steinhart, B | 1 |
| Stellpflug, SJ | 1 |
| Roberts, DJ | 1 |
| Boora, K | 1 |
| Cummings, MR | 1 |
| Marshall, DR | 1 |
| Macaluso, M | 1 |
| Zackula, R | 1 |
| D'Empaire, I | 1 |
| Baker, B | 1 |
| Liow, K | 1 |
| Preskorn, SH | 1 |
| Barczyński, B | 2 |
| Buszewicz, G | 1 |
| Łuszczki, JJ | 1 |
| Bańka, K | 1 |
| Tutaj, K | 1 |
| Mróz, T | 1 |
| Wielosz, M | 2 |
| Mądro, R | 1 |
| Tutka, P | 2 |
| Dersch, R | 1 |
| Zwernemann, S | 1 |
| Voderholzer, U | 1 |
| Skjei, KL | 1 |
| Kessler, SK | 1 |
| Abend, NS | 1 |
| Takechi, K | 1 |
| Suemaru, K | 1 |
| Kawasaki, H | 1 |
| Araki, H | 1 |
| Aubin, HJ | 1 |
| Welsh, CJ | 1 |
| Doyon, S | 1 |
| Belson, MG | 1 |
| Kelley, TR | 1 |
| Balit, CR | 1 |
| Lynch, CN | 1 |
| Isbister, GK | 1 |
| Park-Wyllie, LY | 1 |
| Antoniou, T | 1 |
| Gamarra, M | 1 |
| Parajuá, JL | 1 |
| Coughlin, PA | 1 |
| Birkinshaw, RI | 1 |
| Oncken, CA | 1 |
| Duckrow, RB | 1 |
| Tracey, JA | 2 |
| Shepherd, G | 1 |
| Velez, LI | 1 |
| Keyes, DC | 1 |
| Chaudron, LH | 1 |
| Schoenecker, CJ | 1 |
| Wah, MF | 1 |
| Wah, LS | 1 |
| Hubbard, R | 1 |
| Lewis, S | 1 |
| West, J | 1 |
| Smith, C | 1 |
| Godfrey, C | 1 |
| Smeeth, L | 1 |
| Farrington, P | 1 |
| Britton, J | 1 |
| Macêdo, DS | 1 |
| de Vasconcelos, SM | 1 |
| dos Santos, RS | 1 |
| Aguiar, LM | 1 |
| Lima, VT | 1 |
| Viana, GS | 1 |
| de Sousa, FC | 1 |
| Ross, S | 1 |
| Williams, D | 1 |
| Solano Remírez, M | 1 |
| Alvarez Frías, MT | 1 |
| González Arencibia, C | 1 |
| Gutiérrez Dubois, J | 1 |
| Llorente Díaz, B | 1 |
| Foley, KF | 1 |
| DeSanty, KP | 1 |
| Kast, RE | 1 |
| Givens, ML | 1 |
| Gabrysch, J | 1 |
| Vidal, C | 1 |
| Skripuletz, T | 1 |
| Rudorfer, MV | 1 |
| Golden, RN | 1 |
| Potter, WZ | 1 |
| Van Wyck Fleet, J | 1 |
| Manberg, PJ | 1 |
| Miller, LL | 1 |
| Harto-Truax, N | 1 |
| Sato, T | 1 |
| Fleck, RJ | 1 |
| Stern, WC | 2 |
| Cato, AE | 1 |
| Peck, AW | 1 |
| Watkinson, C | 1 |
| Chouinard, G | 1 |
| Annable, L | 1 |
| Langlois, R | 1 |
| Popli, AP | 1 |
| Tanquary, J | 1 |
| Borowski, TB | 1 |
| Kirkby, RD | 1 |
| Kokkinidis, L | 1 |
| Gittelman, DK | 1 |
| Kirby, MG | 1 |
| Swartz, CM | 1 |
| Pollock, BG | 1 |
| Sweet, RA | 1 |
| Kirshner, M | 1 |
| Reynolds, CF | 1 |
| Harris, CR | 1 |
| Gualtieri, J | 1 |
| Stark, G | 1 |
| Settle, EC | 2 |
| Tilton, P | 1 |
| Dunner, DL | 1 |
| Zisook, S | 1 |
| Billow, AA | 1 |
| Batey, SR | 2 |
| Johnston, JA | 2 |
| Ascher, JA | 3 |
| Paris, PA | 1 |
| Saucier, JR | 1 |
| Hébert, S | 1 |
| Damaj, MI | 1 |
| Slemmer, JE | 1 |
| Carroll, FI | 1 |
| Martin, BR | 1 |
| Selvaraj, N | 1 |
| Drachman, DA | 1 |
| Ravin, P | 1 |
| Knorr, JR | 1 |
| Weihs, KL | 1 |
| Houser, TL | 1 |
| Donahue, RM | 1 |
| Dunlop, H | 1 |
| Ayers, S | 1 |
| Tobias, JD | 1 |
| Mainie, I | 1 |
| McGurk, C | 1 |
| McClintock, G | 1 |
| Robinson, J | 1 |
| Enns, MW | 1 |
| Conway, CR | 1 |
| Nelson, LA | 1 |
| Cox, A | 1 |
| Anton, C | 1 |
| Wooltorton, E | 1 |
| Cassidy, N | 1 |
| Casey, PB | 1 |
| Ali, I | 1 |
| Pesola, GR | 1 |
| Avasarala, J | 1 |
| White, P | 1 |
| Lineberry, CG | 1 |
| Davidson, J | 2 |
| Khayrallah, MA | 1 |
| Feighner, JP | 1 |
| Stark, P | 1 |
| Davidson, JR | 1 |
| Goldberg, JP | 1 |
| Hayes, PE | 1 |
| Kristoff, CA | 1 |
| Sheehan, DV | 1 |
| Welch, JB | 1 |
| Fishman, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study[NCT00001483] | Phase 2 | 75 participants | Interventional | 1995-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for bupropion and Seizures
| Article | Year |
|---|---|
Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.
Topics: Bupropion; Female; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Randomized Co | 2020 |
Factors associated with seizure development after bupropion overdose: a review of the toxicology investigators consortium.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Humans; | 2021 |
An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System.
Topics: Adolescent; Adult; Aged; Bupropion; California; Dose-Response Relationship, Drug; Female; Humans; In | 2014 |
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Topics: Benzazepines; Bupropion; Chest Pain; Dose-Response Relationship, Drug; Humans; Hypertension; Nicotin | 2015 |
Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
Topics: Bupropion; Clinical Trials as Topic; Consumer Product Safety; Delayed-Action Preparations; Dopamine | 2002 |
Zyban-- is there a cause for concern?
Topics: Animals; Antidepressive Agents, Second-Generation; Area Under Curve; Bupropion; Drug Overdose; Half- | 2002 |
Bupropion: risks and benefits.
Topics: Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Humans; Seizures; Smoking Cessation; T | 2005 |
Bupropion: pharmacology and therapeutic applications.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Depressive Disorder; | 2006 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trial | 1984 |
Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Imi | 1983 |
Bupropion sustained release: side effect profile.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Delayed-Actio | 1998 |
Bupropion overdose in an adolescent.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Dr | 2001 |
Seizures and bupropion: a review.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Body Weight; Bupropion; Cohort Studies; | 1989 |
Adverse reactions to five new antidepressants.
Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; | 1986 |
8 trials available for bupropion and Seizures
| Article | Year |
|---|---|
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trial | 1984 |
Overview of clinically significant adverse reactions to bupropion.
Topics: Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, | 1983 |
Bupropion plasma levels and CYP2D6 phenotype.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Cytochrome P-450 CYP2D6; Depressive Disor | 1996 |
A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Second-Gene | 1998 |
Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
Topics: Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Delayed-Act | 2000 |
A 102-center prospective study of seizure in association with bupropion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Depressive Disorder; Drug Administration Sche | 1991 |
Bupropion dosing recommendations.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Drug Administration | 1990 |
Bupropion for depression.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; | 1989 |
82 other studies available for bupropion and Seizures
| Article | Year |
|---|---|
The Timing of Clinical Effects of Bupropion Misuse Via Insufflation Reported to a Regional Poison Center.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Insufflation; Poisons; Seizures | 2022 |
Disposition, outcomes, and lengths of stay due to bupropion overdose at a tertiary care center with a medical toxicology service.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Humans; Seizures; Tertiary Care | 2022 |
Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxicity; Drug Overdose; Fema | 2022 |
Tardive myoclonic focal seizures after electroconvulsive therapy, lithium and bupropion treatment
Topics: Bupropion; Electroconvulsive Therapy; Electroencephalography; Humans; Lithium; Seizures | 2022 |
The role of decision tree and machine learning models for outcome prediction of bupropion exposure: A nationwide analysis of more than 14 000 patients in the United States.
Topics: Bupropion; Decision Trees; Depressive Disorder, Major; Humans; Machine Learning; Retrospective Studi | 2023 |
Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion exposures.
Topics: Adult; Arrhythmias, Cardiac; Bupropion; Female; Humans; Long QT Syndrome; Male; Retrospective Studie | 2023 |
Pediatric Bupropion Ingestions in Adolescents vs. Younger Children-a Tale of Two Populations.
Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxicity; Child; | 2020 |
Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxicity; Dyskinesia, | 2020 |
Pediatric Toxidrome Simulation Curriculum: Bupropion Overdose.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Cardiopulmonary Resuscitation; Clin | 2019 |
New-Onset Seizure in Patient Medicated With Bupropion for Smoking Cessation: A Case Report.
Topics: Aged; Bupropion; Female; Humans; Seizures; Smoking Cessation | 2020 |
Bupropion With Clozapine: Case Reports of Seizure After Coadministration.
Topics: Antipsychotic Agents; Bupropion; Clozapine; Female; Humans; Male; Seizures; Smoking Cessation | 2021 |
Bupropion associated seizures following acute overdose: who develops late seizures.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Dose-Response Relationship, | 2020 |
Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine.
Topics: Adolescent; Adult; Bupropion; Cyproheptadine; Drug Overdose; Female; Humans; Male; Seizures; Seroton | 2021 |
Acute dystonia following epileptic seizure after bupropion intoxication.
Topics: Bupropion; Depressive Disorder, Major; Dystonia; Humans; Seizures; Smoking Cessation | 2021 |
A 19-Year-Old Woman with a History of Depression and Fatal Cardiorespiratory Failure Following an Overdose of Prescribed Bupropion.
Topics: Adolescent; Adult; Bupropion; Depression; Drug Overdose; Female; Humans; Seizures; Shock, Cardiogeni | 2021 |
27-year-old woman • postpartum seizures • PTSD • history of depression • Dx?
Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression, Postpartum; Female; Humans; Seizure | 2021 |
Concurrent Electroconvulsive Therapy and Bupropion Treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Combined Mod | 2017 |
Seizure secondary to Bupropion extended release preparation: A report.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depres | 2017 |
Second-generation anti-depressants and risk of new-onset seizures in the elderly.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; | 2018 |
A case of recurrent seizures: Drug-drug interaction between low-dose clozapine and extended-release bupropion.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Clozapine; Delayed | 2019 |
Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus.
Topics: Animals; Anticonvulsants; Bupropion; CA3 Region, Hippocampal; Cell Death; Dose-Response Relationship | 2013 |
Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxins; Drug Overdose; Electrocard | 2013 |
Bupropion abuse and overdose.
Topics: Antidepressive Agents; Bupropion; Drug Overdose; Humans; Seizures; Substance-Related Disorders; Toba | 2014 |
Occipital seizures and visual pseudohallucinations associated with the addition of bupropion to clozapine: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Clozapine; Drug Therapy, Combination; El | 2015 |
A 12-year-old girl with seizures after intentional drug overdose. Bupropion overdose.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Child; Diagnosis, Differential; Drug Overdose; | 2015 |
Atypical Findings in Massive Bupropion Overdose: A Case Report and Discussion of Psychopharmacologic Issues.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Electrocardiography; Fema | 2016 |
Multiple seizures after bupropion overdose in a small child.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Child; Drug Overdose; Emergency Service, Hospit | 2008 |
Unintentional ingestion of bupropion in children.
Topics: Bupropion; Child, Preschool; Dopamine Uptake Inhibitors; Female; Hallucinations; Humans; Hypertensio | 2010 |
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2008 |
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
Topics: Adolescent; Adult; Aged; Angioedema; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovas | 2008 |
Incidence and onset of delayed seizures after overdoses of extended-release bupropion.
Topics: Adolescent; Adult; Aged; Bupropion; Chi-Square Distribution; Child; Child, Preschool; Dopamine Uptak | 2009 |
The outcome of unintentional pediatric bupropion ingestions: a NPDS database review.
Topics: Accidents; Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Affect; Age Factor | 2010 |
Seizures induced by recreational abuse of bupropion tablets via nasal insufflation.
Topics: Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Bupropion; Diagnosis, D | 2010 |
Which xenobiotic(s) could be responsible for the radiologic findings below? Answer: any proconvulsant xenobiotic, in this case tramadol, bupropion, and nortriptyline.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycli | 2010 |
Generalized seizure in three adolescents with bupropion overdose.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Female; Humans; Male | 2010 |
Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings.
Topics: Adult; Age Factors; Brain; Bupropion; Cohort Studies; Electroencephalography; Female; Humans; Male; | 2010 |
Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice.
Topics: Animals; Anticonvulsants; Brain; Bupropion; Dopamine Uptake Inhibitors; Dose-Response Relationship, | 2011 |
New obesity pill: new hopes, old fears.
Topics: Anti-Obesity Agents; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; D | 2010 |
Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion.
Topics: Adrenergic Uptake Inhibitors; Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Bupr | 2011 |
Stimulus-induced rhythmic, periodic, or ictal discharges in a 13-year-old girl after an overdose and respiratory arrest.
Topics: Adolescent; Baclofen; Bupropion; Drug Overdose; Female; Heart Arrest; Humans; Periodicity; Seizures | 2011 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; | 2011 |
Seizure induced by insufflation of bupropion.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Humans; Insufflation; Male; Seizure | 2002 |
Bupropion exposures: clinical manifestations and medical outcome.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Antidepressive Agents, Second-Generation; Bupropion | 2002 |
Bupropion poisoning: a case series.
Topics: Accidents, Home; Adult; Australia; Bupropion; Child, Preschool; Dopamine Uptake Inhibitors; Drug Ove | 2003 |
Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Benzoxazines; Bupro | 2003 |
[Convulsive episode secondary to bupropion in a patient not included in a risk group].
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Humans; Male; Risk Factors; Seizures | 2003 |
Zyban: increasing the workload in an accident and emergency department?
Topics: Adult; Aged; Bupropion; Dizziness; Dopamine Uptake Inhibitors; Emergency Service, Hospital; Female; | 2003 |
Seizure associated with sleep deprivation and sustained-release bupropion.
Topics: Adult; Bupropion; Delayed-Action Preparations; Humans; Male; Seizures; Sleep Deprivation; Smoking Ce | 2003 |
Bupropion (amfebutamone): French pharmacovigilance data.
Topics: Angioedema; Bupropion; Cardiovascular Diseases; France; Humans; Hypersensitivity; Seizures; Smoking | 2004 |
Intentional bupropion overdoses.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Child; Drug Overdose; Female | 2004 |
Bupropion and breastfeeding: a case of a possible infant seizure.
Topics: Adult; Antidepressive Agents, Second-Generation; Breast Feeding; Bupropion; Depressive Disorder; Fem | 2004 |
Convulsant and anticonvulsant effects of bupropion in mice.
Topics: Animals; Anticonvulsants; Bupropion; Convulsants; Dose-Response Relationship, Drug; Electroshock; Ka | 2004 |
Generalized seizure in a Mauritian woman taking bupropion.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Seizures; Smoking Cessation | 2004 |
Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Death, Sudden; Female; Hu | 2005 |
Cocaine alters catalase activity in prefrontal cortex and striatum of mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Anticonvulsants; Bupropion; Catalase; Catecholamines; Cocaine | 2005 |
Bupropion: seizures in an infant exposed through breast-feeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Bupropion; Contraindications; Dopamine Upt | 2005 |
[Convulsions in association with bupropion].
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Seizures; Smoking Cessat | 2005 |
Cardiotoxicity associated with accidental bupropion ingestion in a child.
Topics: Bradycardia; Bupropion; Cardiopulmonary Resuscitation; Child, Preschool; Dopamine Uptake Inhibitors; | 2007 |
Bupropion interference with immunoassays for amphetamines and LSD.
Topics: Amphetamines; Antidepressive Agents, Second-Generation; Bupropion; Drug Interactions; False Positive | 2007 |
Absence of orthostatic hypotension in depressed patients treated with bupropion.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Blood Pressure; Bupropion; Depression; Ele | 1981 |
Antidepressant-associated seizures.
Topics: Antidepressive Agents; Bupropion; Drug Monitoring; Epilepsies, Partial; Humans; Seizures | 1994 |
Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures.
Topics: Amphetamine; Animals; Antidepressive Agents; Bupropion; Desipramine; Male; Mice; N-Methylaspartate; | 1993 |
A seizure following bupropion overdose.
Topics: Adult; Bupropion; Depressive Disorder; Drug Overdose; Female; Humans; Seizures | 1993 |
Advancing age may inhibit antidepressant-induced seizure.
Topics: Age Factors; Bulimia; Bupropion; Humans; Middle Aged; Seizures | 1993 |
Fatal bupropion overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Dopamine; Drug Overdose; Fatal Outcome; | 1997 |
Bupropion and guanfacine.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with | 1998 |
ECG conduction delays associated with massive bupropion overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Arrhythmias, Cardiac; Bupropion; Delirium; Drug Ove | 1998 |
Bupropion (Zyban, sustained-release tablets): reported adverse reactions.
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Bupropion; Canada | 1999 |
Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Topics: Animals; Body Temperature; Bupropion; Cocaine; Discrimination, Psychological; Female; Male; Membrane | 1999 |
Myocardial infarction, seizure and an abnormal head CT scan.
Topics: Bupropion; Contrast Media; Diagnosis, Differential; Dopamine Uptake Inhibitors; Female; Humans; Midd | 1999 |
Bupropion (Zyban, sustained-release tablets): update.
Topics: Bupropion; Canada; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Hypoglycemia; Seizures; Smoki | 2000 |
Seizures after buproprion overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Female; Follow-Up Studies | 2001 |
Seizure during combination of trimipramine and bupropion.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depressive Di | 2001 |
The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bupropion; Cyclohexanols; Electroconvuls | 2001 |
Safety profile of bupropion for chronic obstructive pulmonary disease.
Topics: Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Lung Diseases, Obstructive; | 2001 |
Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness.
Topics: Bupropion; Contraindications; Dopamine Uptake Inhibitors; Humans; Mortality; Seizures; Serum Sicknes | 2002 |
Bupropion (Zyban) toxicity.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Drug Overdose; Female; Humans; Ireland; | 2002 |
Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department.
Topics: Adult; Alcohol Withdrawal Seizures; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; A | 2002 |
Interaction of intra-articular steroids and bupropion.
Topics: Adult; Anti-Inflammatory Agents; Bupropion; Child; Drug Interactions; Humans; Methylprednisolone; Me | 2002 |
Convulsions and hypersensitivity reactions linked to bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Hypersensitivity; Seizures; Smoking Ces | 2002 |
Bupropion dose, seizures, women, and age.
Topics: Adult; Age Factors; Antidepressive Agents; Bupropion; Dose-Response Relationship, Drug; Female; Huma | 1990 |
A case of bupropion-induced seizure.
Topics: Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Bupropion; Female; Humans; Panic; Prop | 1986 |